Blog
2 Marijuana Stocks to Watch As New York Legalizes Recreational Pot
So it's a done deal: after months, if not years, of promise and hope, New York has legalized recreational marijuana (it did so with medical pot in 2014). Three noted cannabis companies are already
A Tech Stock Worth Buying Before Catalysts Send It Higher
Analog Devices (NASDAQ: ADI) has had a wild ride on the stock market in 2021 thanks to the broader tech sell-off, but investors looking to take advantage of fast-growing markets such as connected
360 DigiTech, inc (QFIN) Q1 2021 Earnings Call Transcript
Image source: The Motley Fool.
360 DigiTech, inc (NASDAQ: QFIN)Q1 2021 Earnings CallMay 29, 2021, 8:30 p.m. ET
Operator
Source Fool.com
The Toronto-Dominion Bank (TD) Q2 2021 Earnings Call Transcript
Image source: The Motley Fool.
The Toronto-Dominion Bank (NYSE: TD)Q2 2021 Earnings CallMay 28, 2021, 3:30 p.m. ET
Operator
Source Fool.com
Canadian Imperial Bank of Commerce (CM) Q2 2021 Earnings Call Transcript
Image source: The Motley Fool.
Canadian Imperial Bank of Commerce (NYSE: CM)Q2 2021 Earnings CallMay 28, 2021, 2:30 p.m. ET
Operator
Source Fool.com
Can a Third Vaccine Shot Help Protect Against Coronavirus Variants?
Moderna (NASDAQ: MRNA) recently announced data from a phase 2 clinical trial testing booster shots of its COVID-19 vaccine. In this video from Motley Fool Live, recorded on May 10, Fool.com
Here's Why 10x Genomics Can't Satisfy Short-Term Investors
10x Genomics (NASDAQ: TXG), which is focused on helping researchers study genomic changes on a cellular level, beat Wall Street expectations in the first quarter, but shares of the company fell
Zoom Earnings on Tuesday: Will They Beat Expectations for the Ninth Time in a Row?
Zoom Video Communications (NASDAQ: ZM) is slated to report its results for its fiscal first-quarter 2022 (which is for the period ended on April 30) after the market closes on Tuesday, June 1.
Will Patent Waivers Hurt COVID-19 Vaccine Companies?
In this video from Motley Fool Live, recorded on May 10, Fool.com contributors Brian Orelli and Keith Speights discuss the potential for the Biden administration to waive patent rights for vaccines
How Long Will Fulgent Genetics Benefit From the Pandemic?
Fulgent Genetics (NASDAQ: FLGT) reported solid first-quarter results, boosted by the company's move into COVID-19 testing. In this video from Motley Fool Live, recorded on May 10, Fool.com
Which Pot Stocks Flew High This Earnings Season?
The smoke has cleared from the inaugural earnings season of 2021 for marijuana companies. Overall they didn't do too badly, with some -- Curaleaf (OTC: CURLF) and Innovative Industrial Properties
This Stock Could Be the Biggest Bargain in the Market
Airline stocks have surged since the autumn as investors have gained confidence that the rapid development and distribution of coronavirus vaccines would tame the COVID-19 pandemic. In fact, many
3 High-Yield Stocks at Rock-Bottom Prices
When stock prices rise, dividend yields fall. Because of that inverse relationship, the rally in the S&P 500 over the past year has pushed the yield on the average stock in that index down to about
3 Great Stocks You Can Buy on Sale
As an investor, your most important job is identifying quality companies that can drive their stocks higher with sustainable results. Everything else is just details.
Still, if you can jump into a
Okta Sets Its Sights on a Big Growth Target
Okta (NASDAQ: OKTA), a provider of cloud software for identity management, has been a steady winner on the market since its 2017 IPO.
The cloud stock has returned 850% since then, and the company
Forget Crypto, Farming Is the Red-Hot Sector in 2021
Investing in cryptocurrencies has its own merits, but it's not for the fainthearted, and it's not an asset class most investors should be constructing a portfolio around. Moreover, if you are
3 Top Dividend Stocks With Yields Over 4%
It's getting tougher to find compelling dividend stocks these days. Following the market's surge over the past year, the average dividend yield of stocks in the S&P 500 is around 1.4%.
However, one
Regeneron Just Got a COVID-19 Boost
Regeneron Pharmaceuticals (NASDAQ: REGN) posted solid first-quarter revenue growth of 38%, which was boosted by sales of its COVID-19 treatment, REGEN-COV. In this video from Motley Fool Live
The 5 Most Impressive Numbers from Pinduoduo's Q1 Earnings Beat
Pinduoduo (NASDAQ: PDD), the third-largest e-commerce company in China in terms of annual revenue, recently posted its first-quarter earnings. It easily surpassed analysts' expectations on the top
Airbus' Bullish Production Plans Aren't Good News for Boeing
Shares of Airbus (OTC: EADSY) surged 9% on Thursday, after the European plane maker told suppliers to get ready for a rapid rebound in jet production. In fact, Airbus plans to boost output of
Better Dividend Stock: Enbridge vs. Exxon
ExxonMobil (NYSE: XOM) has a yield of 5.8% backed by more than 35 years of annual dividend increases. Enbridge (NYSE: ENB) has a yield of 7% with over 25 years of yearly dividend hikes. They are
3 Stocks to Hold for the Next 20 Years
When you're hunting for stocks to add to your portfolio, the best way to fuel and maximize your returns is to focus on high-quality companies that you can hold on to for many years. Not all stocks
6 Hard-to-Believe Chinese Tech Stock Facts
Over the past two decades, many investors bought Chinese tech stocks because they seemed to offer more growth potential than their American counterparts. On the surface, the comparisons seemed
Investors Who Worry About Bitcoin Should Remember These 3 Things
With some cryptocurrencies down 40% or more from their recent highs, crypto investors may be nervous about what comes next. But despite the volatility, there are at least three good reasons for
Better Crypto Stock: Coinbase Global vs. Silvergate Capital
It's still the wild west for the cryptocurrency market. To date, most owners of cryptos hold or trade them, because they think they will go up in value. Few use them as a form of digital payment or